Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
31 August 2018 Photo Godfrey Ndoda
UFS Mobile Clinic - an exemplary framework of innovation
Free State Department of Health and the UFS Faculty of Health Sciencesentered into a partnership set to improve primary health care in the Free State society.

The Coordinator of Community Engagement and Rural Health in the Faculty of Health Sciences, Dr René Botha, described the unveiling and handing-over ceremony of the University of the Free State (UFS) Faculty of Health Sciences’ Mobile Clinic as “an auspicious and phenomenal occasion in the history of the faculty, and the institution as a whole”.

This mobile healthcare service will align itself with the current mobile service offered by the Free State Department of Health (FSDH) and will include an optometry service. This is the first service of its kind and aims to expose students and the broader community to mobile primary healthcare on rural platforms.

This collaboration between the Faculty of Health Sciences and the FSDH is believed to change and improve lives.   

“The purpose of the clinic is to enrich current primary healthcare measures that were implemented through valuable collaborations. This will result in the betterment of community members who have limited access to healthcare resources,” explained Dr Botha.

UFS medical students have been working on a continuous healthcare programme that started in 2016. The programme operates in areas in the southern Free State, where students engage with the community, schools, clinics, and are making home visits to residents in the area. The main purpose of the programme is to find solutions to key healthcare problems in the region. 

The MEC of Health, Montseng Tsiu, addressed the audience and explained, “implementing primary healthcare holistically through the mobile clinic, will benefit residents in rural areas who have a lack of facilities”. 

According to Prof Francis Petersen, UFS Rector and Vice-Chancellor, the mobile clinic is an example of the innovation framework that cultivates the university’s mandate. The mandate stipulates the creation and maintenance of equitable partnerships with the province, the FSDH, the Department of Education, and many other crucial stakeholders that will ensure the imparting of knowledge, excellence, and quality in contributing to society.

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept